名稱 | CCDC6-RET WT/BaF3 |
型號 | CBP73214 |
報(bào)價(jià) | ![]() |
特點(diǎn) | CCDC6-RET WT/BaF3,母細(xì)胞:BaF3 |
產(chǎn)品搜索
相關(guān)文章
- IL9細(xì)胞篩選模型
- 【連載-Toll樣受體系列2】TLR7激動(dòng)劑藥物細(xì)胞篩選模型
- 對ATCC細(xì)胞培養(yǎng)時(shí)的試劑有何要求?
- 人乳頭瘤病毒HPV核酸檢測標(biāo)準(zhǔn)品
- 國內(nèi)研究者Cell Research:韓春雨NgAgo有效
- 細(xì)胞株的核型分析實(shí)驗(yàn)操作流程分析
- 雙面PD1,Blocker已成卷王,agonist賽道你上車了嗎?
- 上海細(xì)胞中心分享細(xì)胞分裂后的三種情況
- 【連載-企業(yè)參考品】 前列腺癌的診斷參考品的選擇
- atcc細(xì)胞培養(yǎng)紫外燈照射的目的與實(shí)踐
聯(lián)系我們
電話:4008750250
號碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73214CCDC6-RET WT/BaF3

- 詳細(xì)內(nèi)容
CBP73214 | |
I. Introduction | |
Cell Line Name: | CCDC6-RET WT/BaF3 |
Host Cell: | BA/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS+1ug/ml puromycin |
Mycoplasma Status: | Negative |
II.Background | |
CCDC6, coiled-coil domain containing 6, has been shown to play a role in the DNA damaging signaling pathway acting as a substrate of ATM (PMID: 17420723). CCDC6 fusions with RET (PMID: 23154560, PMID: 26078337) and BRAF (PMID: 26314551) have been observed in multiple cancer types. | |
III. Representative Data | |
1. WB of CCDC6-RET WT/BaF3WT | |
2. Sanger of CCDC6-RET WT/BaF3 Figure 2. Breakpoint of CCDC6-RET WT/BaF3 | |
2. Anti-proliferation assay | |
Figure 3. CTG assay of for CCDC6-RET WT/BaF3 Stable Cell Line,the Gi50 was 137.3nM. |